Fire Well Holdings Limited is announcing today the appointment by PHASE Scientific Int’l Ltd (PHASE) as the distributor for their INDICAID COVID-19 rapid antigen test product . 

Fire Well Holdings Limited今天宣佈接受相達生物科技(相達)委任為其新冠肺炎快速測試產品「妥析」抗原測試作為香港代理商。

 

 

As the fourth wave of the COVID-19 pandemic sweeps through Hong Kong, the transmission risks and demand for coronavirus testing in Hong Kong is spiralling.  In view of this imminent need, PHASE Scientific International (PSI or PHASE) has released to the market its locally developed and manufactured COVID-19 Rapid Antigen Test to provide Hong Kong citizens with a reliable, low-price, and fully self-administered testing option.

本港新冠肺炎疫情爆發第四波,進一步令本港的檢測需求急速上升,相達生物科技國際有限公司推出新冠病毒快速抗原測試產品妥析,為市民提供香港研發和製造、便宜易用又快速的選項。Fire Well 將主力協助相達生物科技開拓銷售渠道, 讓公眾能夠購買和自行使用該產品。

PHASE is launching a new, locally developed testing product – the COVID-19 Rapid Antigen Test, which has gone through clinical trials in the United States and been certified by the EU (CE mark).  This Rapid Antigen Test uses nasal swab samples for testing and is easy to use – no assistance from a trained health professional is required in the entire process.  The test result is available in 20 minutes with high sensitivity (96%) and specificity (99%), which enables detection of lower viral load samples against competitive products.  At an affordable retail price of HKD120, PHASE believes most Hong Kong people would be keen on getting tested for COVID-19 more frequently.

妥析是在香港自行研發並已在美國進行臨床試驗,同時已取得歐盟認證的新冠病毒抗原快速測試。這項快速測試利用鼻腔拭子樣本進行檢測,操作簡單,全程無需醫護人員協助,準確率高達96%的靈敏度(真陽性率)和99%的特異度(真陰性率),比市場上其他檢測產品能更有效於低病毒量樣本中作準確檢測,讓公眾能夠在20分鐘內取得初步檢驗結果,零售價格為120港元,讓大眾能夠以可負擔價格自行進行測試。
 

COVID-19 Rapid Antigen Test as a fast, low-price and reliable complement to PCR test/ 快速測試便宜可靠 方便較頻密自行檢測 與核酸測試互補

Dr. Ricky Chiu, Founder, Chairman & CEO of PHASE, said, “Under the threat of the fourth wave of the COVID-19 pandemic, many citizens feel the urge to get tested immediately. Although the PCR test can put people at ease, those tested negative could be infected just after the PCR test as there are invisible chains of transmission in the community. A low-price and simple-to-use, self-administered rapid test can provide a second line of defense and can complement the PCR test in facilitating frequent testing by the mass public on regular bases. Society should not get hung up on accuracy of the test alone but should consider testing strategies balancing price, speed, and popularisation of use, and which can optimize protection for the public."

相達生物科技創辦人、主席兼行政總裁招彥燾博士說:「面對來勢洶洶的新冠病毒第四波疫情,不少市民都想馬上進行檢測。PCR核酸檢測雖然可讓普羅大眾放心,但因為社區存在隱形傳播縺,即使核酸檢測報告呈陰性,亦不代表下一分鐘不會受感染。價格較低、操作簡單的快速測試可以提供第二條檢測防線,讓市民可以隨時自行測試,而且價格較低讓市民大眾可以較頻密地重複測試,與核酸檢測起相輔相成的效果。社會不應只執著檢測的準確度,而應該采納平衡價格、速度及普及性,可達至更立體成效的檢測模式。」

In addition to the COVID-19 Rapid Antigen Test, PHASE, in partnership with ONCO Medical Laboratory Ltd, has become one of the nine government recognized COVID-19 PCR testing centres in November.  As a responsible company and to deliver complete peace of mind to the public, PHASE pledges to provide free PCR tests to customers who have been tested positive in the COVID-19 Rapid Antigen Test.

除研發和生產新冠病毒快速測試外,相達生物科技也伙拍安球醫學化驗所,自本(11)月起成爲9所政府認可進行2019冠狀病毒病(COVID-19)核酸病毒檢測的本地醫療檢測機構之一。作為有承擔的檢測公司,相達生物科技將會跟進陽性結果的快速測試個案,免費為相關人士提供PCR核酸檢測,進一步覆核檢測結果,確保萬無一失,讓市民放心安心。
 

About PHASE Scientific/關於相達生物科技國際有限公司  www.phasescientific.com
PHASE Scientific,  founded by Hong Kong-born scientist Dr. Ricky Chiu (PhD in biotechnology, UCLA), is a fast-growing biotech company building diagnostic tools to empower people with better information, products and services about their health.  Headquartered in Hong Kong, our global footprint includes R&D and manufacturing facilities in Southern California and offices in Mainland China. Phase Scientific has raised more than USD23 million to date, including funding from Bill and Melinda Gates Foundation.

相達生物科技是一家由香港人招彥燾生物工程博士(美國加州大學洛杉磯分校,UCLA)創立並快速成長的生物技術公司。相達的檢測工具可為人們提供更優良的健康信息、產品與服務,幫助提升健康管理水平。相達總部位於香港,在美國南加州設有研發和生產基地,也在中國大陸設立了子公司。公司成立至今累計取得2,300萬美元融資,包括來自蓋茨基金會的資金 。

 

About Fire Well/關於Fire Well Holdings Limited
Fire Well Holdings Limited is established by a team of seasoned startup investors. The mission of Fire Well is to seek and provide state-of-the-art services for improving the wellness of individuals and communities. Through their investors' networks, the Fire Well team has consistent exposure and access to latest technology in various domains including healthcare, medical, lifestyle and wellness.

Fire Well Holdings Limited由俱備資深科創投資經驗的團隊成立, 目標為引入全球最先進的科創產品和服務,改善個人和社群健康。 通過Fire Well的投資網路,團隊能夠掌握和瞭解第一手的醫療、生活方式和健康等各個領域的最新技術。